About 9 results found for searched term "68-88-2" (0.171 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M3906 | Macranthoidin B | Others |
| Macranthoiside I | ||
| Macranthoidin B is an active natural saponin. | ||
| M11535 | RG7800 | DNA/RNA Synthesis |
| RG-7800; RG 7800; RO6885247; RO-6885247; RO 6885247 | ||
| RG7800 is a small molecule SMN2 splicing modifier. RG7800 has the potential to be used in spinal muscular atrophy. RG7800 corrects selective splicing of the human SMN2 gene in the brain of a transgenic SMA model mouse, leading to an increase in SMN protein in the brain. | ||
| M17929 | 1,3,6-trihydroxy-2-methyl-9,10-anthraquinone-3-O-α-L-rhamnopyranosyl-(1->2)-β-D-glucopyranoside | Others |
| 1,3,6-trihydroxy-2-methyl-9,10-anthraquinone-3-O-α-L-rhamnopyranosyl-（1->2）-β-D-glucopyranoside | ||
| M21035 | LCH-7749944 | PAK |
| GNF-PF-2356 | ||
| LCH-7749944 (GNF-PF-2356) is a novel and potent p21-activated kinase 4 (PAK4) inhibitor with an IC50 of 14.93 μM and has less potently inhibitory effect against PAK1, PAK5 and PAK6. LCH-7749944 causes successful inhibition of EGFR activity due to its inhibitory effect on PAK4. | ||
| M21306 | UNC6852 | Histone Methyltransferase |
| UNC6852 is a PROTAC technology-based, selective PRC2 degradation agent containing an EED ligand and a von Hippel-Lindau ligand with an IC50 value of 247 nM for EED action. | ||
| M24703 | Cergutuzumab amunaleukin | IL Receptor/Related |
| CEA-IL2v; RG 7813; RO 6895882 | ||
| Cergutuzumab amunaleukin (CEA-IL2v) is a monomeric carcinoembryonic antigen (CEA)-targeted IL-2 variant-based immunocytokine. Cergutuzumab amunaleukin has immunostimulating and antineoplastic activities. | ||
| M52765 | α-Conotoxin PeIA | AChR/AChE |
| α-Conotoxin PeIA is an analgesic α-conotoxin.α-Conotoxin PeIA inhibits the α6β4, α9α10 and α3β2 nAChR.α-Conotoxin PeIA is also a potent inhibitor of N-type calcium channel via GABAB receptor activation. | ||
| M53234 | Hemopressin(rat) | Cannabinoid |
| Hemopressin(rat) is a nonapeptide derived from the α1-chain of hemoglobin, is originally isolated from rat brain homogenates. | ||
| M57104 | (S,R,S)-AHPC-C3-NH2 TFA | E3 Ligase Ligand-Linker Conjugates |
| (S,R,S)-AHPC-C3-NH2 TFA (VH032-C3-NH2 TFA) is a synthesized E3 ligase ligand-linker conjugate that incorporates the VH032 based VHL ligand and a linker used in PROTAC technology. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
